| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.08 | 0.06 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |